Clinical significance of FGF-23 in Chronic Kidney Disease Patients

Journal Title: Scholars Journal of Applied Medical Sciences - Year 2015, Vol 3, Issue 2

Abstract

Fibroblast growth factor 23 (FGF-23) is a potent regulator of serum phosphate level. In CKD, circulating FGF-23 levels gradually increase with declining renal function. Higher FGF-23 level was associated with higher atherosclerosis score. We aimed to study the correlation between FGF-23 and the parameters that have effects on morbidity and mortality in CKD patients and to establish its role as biomarker of cardiovascular disease risk in these patients. This study comprises 80 subjects divided into three groups: group I (40 patients with CKD on regular HD), group II (20 patients with CKD on conservative treatment) group 3 (20 healthy subjects as a control). All patients and controls were subjected to the following: echocardiography, carotid duplex and laboratory investigations including serum calcium, phosphate, parathyroid hormone, alkaline phosphatase, creatinine, blood urea, Iron profile (serum iron, serum ferritin, Tsat, TIBC, FGF23. The laboratory data showed significant increase in creatinine, urea, phosphorus, CaPh product, PTH and FGF-23 with significant decrease in serum calcium and ferritin in group 1 & 2 compared to the controls. There were a statistically significant increase in IVST, PWT, LVM, LVMI and CIMT in group 1 & 2 compared to the controls. FGF-23 showed a positive correlation with creatinine, urea, PTH, CaPh, LVMI & CIMT and negative correlation with ferritin, Hb & HCT. We concluded that elevated FGF-23 level was independently associated with faster progression of CKD, therapy-resistant secondary hyperparathyroidism and increased cardiovascular risk in CKD patients and so, could represent a promising therapeutic target that might improve the fatal prognosis of patients with CKD. Keywords: CKD, Hemodialysis, FGF-23, PTH, LVM, CIMT.

Authors and Affiliations

Manar Raafat, Mona Madkour, Amna Metwaly, Fatma Mohammad Nasr, Osama Mosbah, Noha El-Sheikh

Keywords

Related Articles

Intentional Self Poisoning Cases Autopsied in a Teaching Hospital in Central Kerala: A Descriptive Study

Abstract: Intentional self-poisoning is a common method of committing suicide globally as well as in India. The present study attempts to analyse successful cases of suicidal intake of poisons. By a retrospective study,...

Idiopathic Thrombocytopenic Purpura in Pregnancy: A Case Report

Abstract: Immune thrombocytopenic purpura (ITP) (platelet count less than 150×109/I) is an autoimmune disorder characterized by persistent thrombocytopenia due to antibody mediated premature destruction of platelets. ITP...

The efforts on using various agricultural substances, proteins or products for the purpose of pleurodesis

Abstract: There are a great number of substances and products all over the world, used for pleurodesis. However, either the pleurodesis successes of these agents are not at the desired level or they reveal various side e...

Ultrasonography of Prostate- An Observational Study

Abstract: Prostate is of great clinical importance and ultrasonography is an ideal diagnostic aid. High frequency transrectal ultrasonography (TRUS) provides a remarkably detailed view of the prostate. This study is aime...

Efficacy of Miniature Punch Grafting Followed By Puvasol Therapy in Refractory Stable Vitiligo

Abstract: Vitiligo affects approximately 2% of the worldwide population regardless of race, ethnic background or gender. When the medical methods are not successful, surgical procedures may be considered with the aim of...

Download PDF file
  • EP ID EP372931
  • DOI -
  • Views 60
  • Downloads 0

How To Cite

Manar Raafat, Mona Madkour, Amna Metwaly, Fatma Mohammad Nasr, Osama Mosbah, Noha El-Sheikh (2015). Clinical significance of FGF-23 in Chronic Kidney Disease Patients. Scholars Journal of Applied Medical Sciences, 3(2), 741-750. https://europub.co.uk./articles/-A-372931